课题基金 / 基金详情

Study on differentiation and apoptosis-inducing therapy for head and neck cancer by vesnarinone

Study on differentiation and apoptosis-inducing therapy for head and neck cancer by vesnarinone
维纳里酮诱导头颈癌分化和凋亡的研究
批准号:
10307051
负责人:
SATO Mitsunobu
金额:
$25.81万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2001

项目摘要

项目成果

SATO Mitsunobu的其他基金

相似基金

相关文献

中文摘要
翻译
1. 当人口腔鳞状细胞癌细胞(BHY、HN: p53野生型(exon4-9))和人唾液癌细胞(HSG、HSG- aza1、HSG- aza3: p53野生型;TYS: p53密码子281^<Asp→Hls>)经vesnarinone处理后,细胞均出现生长抑制和G1阻滞,其中p21^<Waf1>、p27^<Kip1>和TSC-22基因上调,p53基因下调。2 .当向携带TYS肿瘤的裸鼠体内注射vesnarinone时,肿瘤生长受到明显抑制,细胞分化为角化细胞和腺泡细胞。Vesnarinone对人口腔鳞状细胞癌和人唾液腺样囊性癌有很好的治疗效果。我们从经vesnarinone处理的TYS细胞中分离并鉴定了人TSC-22基因。(1)体外培养和裸鼠培养的人唾液癌细胞中,TSC-22基因下调可显著加速肿瘤生长,上调可显著抑制非锚定生长。(2) TYS细胞中TSC-22蛋白的过度表达导致抗癌药物(5-FU和CDDP)或放疗对细胞凋亡的诱导增强。(3) TSC-22基因由3个外显子组成。转录起始位点分别位于TATA box - like序列下游7bp和29bp处。TSC-22启动子区包含NF-kB、MyoD、AP-1、PU、C/EBP、p53、C- myb、Sp1、NF1或Smad.5等转录因子的推定结合位点。在TYS细胞中,p21Waf1启动子中存在Sp1和Sp3转录因子与vesnarin -responsive element (Sp1-1和Sp1-2位点)结合。Vesnarinone诱导TYS细胞组蛋白超乙酰化。
英文摘要
1. When human oral squamous cell carcinoma cell lines (BHY, HN: p53 wild type (exon4-9)) and human salivary cancer cell lines (HSG, HSG-AZA1, HSG-AZA3: p53 wild type; TYS : p53 codon 281^<Asp→Hls>) were treated with vesnarinone, inhibition of cell growth and induction of G1 arrest occurred in all of the treated cells, where up-regulation of p21^<Waf1>, p27^<Kip1> and TSC-22 genes as well as down-regulation of p53 gene were detected.2. When vesnarinone was administered per os into the nude mice bearing TYS tumors, significant inhibition of the tumor growth as well as cellular differentiation into keratinocyte and acinar cells occurred.3. Vesnarinone was very therapeutically effective for human oral squamous cell carcinoma or for human salivary adenoid cystic carcinoma.4. We isolated and characterized human TSC-22 gene from the TYS cells treated with vesnarinone.(1) Down-regulation of TSC-22 gene in human salivary cancer cells, grown in vitro and in nude mice, caused the marked acceleration of tumor growth and up-regulation of the gene inhibited significantly anchorage-independent growth.(2) Overexpression of TSC-22 protein in TYS cells resulted in the augmented induction of apotosis by anti-cancer drugs (5-FU and CDDP) or radiation.(3) TSC-22 gene was comprised of 3 exons. Transcription initiatin sites were located at 7bp and 29bp downstream from TATA box like sequence. TSC-22 promoter region contained putative binding sites for transcription factor such as NF-kB, MyoD, AP-1, PU, C/EBP, p53, c-Myb, Sp1, NF1 or Smad.5. Sp1 and Sp3 transcription factors bound to the vesnarinone-responsive element (Sp1-1 and Sp1-2 sites) present in p21Waf1 promoter in TYS cells.6. Vesnarinone induced the histone hyperacetylation in TYS cells.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
Daisuke Uchida: "Overexpression of TSC-22(TGF-β stimulated clone 22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line"Lab.Invest.. 80(6). 955-963 (2000)
Daisuke Uchida:“TSC-22(TGF-β 刺激的克隆 22)的过表达显着增强了人唾液腺癌细胞系中 5-氟尿嘧啶诱导的细胞凋亡”Lab.Invest.. 80(6) (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Keiko Aota: "5-Fluorouracil induces apoptosis through the suppression of NP-κB activity in human salivary gland cancer cells"Biochem Biophys Res Commun. 278(3). 1168-1174 (2000)
Keiko Aota:“5-氟尿嘧啶通过抑制人唾液腺癌细胞中的 NP-κB 活性来诱导细胞凋亡”Biochem Biophys Res Commun. 278(3)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mohammad O.Hoque: "Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer"Int J Oncol. 19(6). 953-958 (2001)
Mohammad O.Hoque:“二氢嘧啶脱氢酶 mRNA 水平与人类口腔鳞状细胞癌中基于 5-氟尿嘧啶的化学免疫放射治疗的反应相关”Int J Oncol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 46 条
    Syntheses of apatite via Ca complexes of amino acids involved innon-collagen protein
    • 批准号:
      22550183
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2010
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Toll-like receptor 4 signaling : Enhancement of therapeutic effect of anti-cancer drugs and radiation in oral Cancer
    • 批准号:
      14207090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.28万
    • 财政年份:
      2002
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Development of the therapy for oral cancer by transduction of iNOS gene in combination with radiotherapy
    • 批准号:
      12557176
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.66万
    • 财政年份:
      2000
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    Lipoteichoic acid : Augmentation of the therapeutic effect of radiation and 5-fluorouracil in head and neck cancer
    • 批准号:
      09557170
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.55万
    • 财政年份:
      1997
    • 负责人:
      SATO Mitsunobu
    • 依托单位:
    海外基金